American Century Companies’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-39,198
| Closed | -$196K | – | 2884 |
|
|
2024
Q4 | $196K | Sell |
39,198
-47,511
| -55% | -$237K | ﹤0.01% | 2784 |
|
|
2024
Q3 | $467K | Buy |
86,709
+33,321
| +62% | +$180K | ﹤0.01% | 2501 |
|
|
2024
Q2 | $177K | Buy |
53,388
+36,528
| +217% | +$121K | ﹤0.01% | 2746 |
|
|
2024
Q1 | $55.1K | Buy |
16,860
+4,107
| +32% | +$13.4K | ﹤0.01% | 2893 |
|
|
2023
Q4 | $44.8K | Buy |
12,753
+1,575
| +14% | +$5.53K | ﹤0.01% | 2852 |
|
|
2023
Q3 | $74.7K | Sell |
11,178
-9,329
| -45% | -$62.3K | ﹤0.01% | 2762 |
|
|
2023
Q2 | $172K | Buy |
20,507
+2,762
| +16% | +$23.2K | ﹤0.01% | 2565 |
|
|
2023
Q1 | $169K | Buy |
17,745
+4,576
| +35% | +$43.5K | ﹤0.01% | 2461 |
|
|
2022
Q4 | $91.7K | Buy |
+13,169
| New | +$91.7K | ﹤0.01% | 2467 |
|